Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNX18P26, or sorting nexin 18 pseudogene 26, is a human pseudogene. It does not encode a functional protein and has no described biological, physiological, or clinical roles. Pseudogenes are typically regarded as genomic DNA sequences similar to normal genes but are nonfunctional; they arise from gene duplication or retrotransposition events and often lack regulatory elements or contain disabling mutations. There are no known functional or therapeutic implications for SNX18P26[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin 18 pseudogene 26 (SNX18P26).